PROCTER & GAMBLE HEALTH | ABBOTT INDIA | PROCTER & GAMBLE HEALTH/ ABBOTT INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | 48.6 | 70.8% | View Chart |
P/BV | x | 10.5 | 17.7 | 59.3% | View Chart |
Dividend Yield | % | 2.0 | 1.2 | 163.1% |
PROCTER & GAMBLE HEALTH ABBOTT INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ABBOTT INDIA Mar-23 |
PROCTER & GAMBLE HEALTH/ ABBOTT INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 22,482 | 23.9% | |
Low | Rs | 3,883 | 16,156 | 24.0% | |
Sales per share (Unadj.) | Rs | 740.7 | 2,517.0 | 29.4% | |
Earnings per share (Unadj.) | Rs | 138.2 | 446.8 | 30.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 479.7 | 32.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 325.00 | 29.2% | |
Avg Dividend yield | % | 2.1 | 1.7 | 122.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 1,480.5 | 30.2% | |
Shares outstanding (eoy) | m | 16.60 | 21.25 | 78.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 7.7 | 81.3% | |
Avg P/E ratio | x | 33.5 | 43.2 | 77.4% | |
P/CF ratio (eoy) | x | 29.8 | 40.3 | 74.0% | |
Price / Book Value ratio | x | 10.3 | 13.0 | 79.2% | |
Dividend payout | % | 68.7 | 72.7 | 94.5% | |
Avg Mkt Cap | Rs m | 76,761 | 410,513 | 18.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 5,636 | 36.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 53,487 | 23.0% | |
Other income | Rs m | 184 | 1,543 | 11.9% | |
Total revenues | Rs m | 12,480 | 55,030 | 22.7% | |
Gross profit | Rs m | 3,247 | 12,055 | 26.9% | |
Depreciation | Rs m | 281 | 700 | 40.2% | |
Interest | Rs m | 8 | 160 | 4.8% | |
Profit before tax | Rs m | 3,142 | 12,738 | 24.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 3,244 | 26.1% | |
Profit after tax | Rs m | 2,295 | 9,494 | 24.2% | |
Gross profit margin | % | 26.4 | 22.5 | 117.2% | |
Effective tax rate | % | 27.0 | 25.5 | 105.9% | |
Net profit margin | % | 18.7 | 17.8 | 105.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 30,251 | 38.7% | |
Current liabilities | Rs m | 6,791 | 12,060 | 56.3% | |
Net working cap to sales | % | 40.0 | 34.0 | 117.7% | |
Current ratio | x | 1.7 | 2.5 | 68.8% | |
Inventory Days | Days | 263 | 87 | 302.5% | |
Debtors Days | Days | 343 | 2 | 15,880.3% | |
Net fixed assets | Rs m | 10,617 | 15,135 | 70.1% | |
Share capital | Rs m | 166 | 213 | 78.1% | |
"Free" reserves | Rs m | 7,265 | 31,248 | 23.2% | |
Net worth | Rs m | 7,431 | 31,460 | 23.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 45,386 | 49.2% | |
Interest coverage | x | 409.1 | 80.7 | 507.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.2 | 46.7% | |
Return on assets | % | 10.3 | 21.3 | 48.5% | |
Return on equity | % | 30.9 | 30.2 | 102.3% | |
Return on capital | % | 42.4 | 41.0 | 103.4% | |
Exports to sales | % | 0 | 0.4 | 0.0% | |
Imports to sales | % | 13.1 | 10.8 | 121.1% | |
Exports (fob) | Rs m | NA | 221 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 5,765 | 27.8% | |
Fx inflow | Rs m | 1,465 | 310 | 473.0% | |
Fx outflow | Rs m | 1,605 | 5,818 | 27.6% | |
Net fx | Rs m | -140 | -5,508 | 2.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 8,934 | 26.4% | |
From Investments | Rs m | -215 | -1,477 | 14.6% | |
From Financial Activity | Rs m | -985 | -6,387 | 15.4% | |
Net Cashflow | Rs m | 1,160 | 1,070 | 108.5% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 75.0 | 69.1% | |
Indian inst/Mut Fund | % | 20.0 | 9.1 | 219.7% | |
FIIs | % | 6.2 | 0.2 | 3,466.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 25.0 | 192.6% | |
Shareholders | 56,778 | 69,382 | 81.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Abbott India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.14% | 0.64% | -0.44% |
1-Month | -3.36% | -7.30% | 2.15% |
1-Year | -0.17% | 15.35% | 49.82% |
3-Year CAGR | -9.52% | 21.27% | 14.21% |
5-Year CAGR | 4.46% | 27.78% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Abbott India share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Abbott India the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Abbott India.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Abbott India.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.